The stock of ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) has decreased by -4.71 when compared to last closing price of 0.44. Despite this, the company has experienced a 12.31% gain in its stock price over the last five trading sessions.
Is It Worth Investing in ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) Right Now?
There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The public float for ZVSA is 4.15M, and at present, short sellers hold a 6.16% of that float. The average trading volume of ZVSA on May 25, 2023 was 1.50M shares.
ZVSA’s Market Performance
ZVSA stock saw a decrease of 12.31% in the past week, with a monthly decline of -16.65% and a quarterly a decrease of -80.60%. The volatility ratio for the week is 12.78%, and the volatility levels for the last 30 days are 15.56% for ZyVersa Therapeutics Inc. (ZVSA). The simple moving average for the past 20 days is -13.72% for ZVSA’s stock, with a -92.46% simple moving average for the past 200 days.
ZVSA Trading at -67.00% from the 50-Day Moving Average
After a stumble in the market that brought ZVSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.34% of loss for the given period.
Volatility was left at 15.56%, however, over the last 30 days, the volatility rate increased by 12.78%, as shares sank -15.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -79.41% lower at present.
During the last 5 trading sessions, ZVSA rose by +14.20%, which changed the moving average for the period of 200-days by -95.72% in comparison to the 20-day moving average, which settled at $0.4771. In addition, ZyVersa Therapeutics Inc. saw -73.56% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ZVSA
Equity return is now at value -56.30, with -40.30 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.
Conclusion
In summary, ZyVersa Therapeutics Inc. (ZVSA) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
